Is there a role for immunocontraception?

Molecular and Cellular Endocrinology

Volumn 335, Issue 1, 2011, Pages 78-88

  McLaughlin, E A ^a   Aitken, R J ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Adjuvant; Contraception; Mucosal immunity; Systemic immunity; Target antigens; Vaccine

Indexed keywords

BONE MORPHOGENETIC PROTEIN 15; CHOLERA TOXIN B SUBUNIT; CHORIONIC GONADOTROPIN BETA SUBUNIT; CONTRACEPTIVE VACCINE; DIPHTHERIA TOXOID; FOLLITROPIN; GONADORELIN; GROWTH DIFFERENTIATION FACTOR 9; HEMOCYANIN; INTERLEUKIN 11; INTERLEUKIN 11 RECEPTOR ALPHA; KEYHOLE LIMPET HEMOCYANIN; LUTEINIZING HORMONE; RECOMBINANT ECTROMELIA VIRUS VACCINE; RECOMBINANT MURINE CYTOMEGALOVIRUS VACCINE; SEX HORMONE; TETANUS TOXOID; UNCLASSIFIED DRUG; VIRUS VACCINE; VIRUS VECTOR;

ANTIBODY TITER; DRUG SAFETY; ECTROMELIA VIRUS; FEMALE INFERTILITY; FERTILIZATION; GENITAL SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOCONTRACEPTION; IMMUNOGENICITY; MALE INFERTILITY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; SPERMATOZOON CAPACITATION; VACCINE PRODUCTION; ZONA PELLUCIDA;

ANIMALS; ANTIGENS; CONTRACEPTION, IMMUNOLOGIC; FEMALE; GENITALIA; GERM CELLS; GLYCOSYLATION; HUMANS; IMMUNITY, MUCOSAL; MALE; PREGNANCY; SEXUALLY TRANSMITTED DISEASES; VACCINES, CONTRACEPTIVE;

EID: 79951578499     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.04.004     Document Type: Review

References (165)

1. Aitken R.J. Contraceptive research and development. Br. Med. Bull. 1979, 35:199-204.
2. Aitken R.J. New techniques in contraception: gossypol, vaccines and GnRH analogues. Proc. Annu. Symp. Eugen Soc. 1983, 19:1-18.
3. Aitken R.J., Baker M.A., Doncel G.F., Matzuk M.M., Mauck C.K., Harper M.J. As the world grows: contraception in the 21st century. J. Clin. Invest. 2008, 118:1330-1343.
4. An G., Huang T.H., Wang D.G., Xie Q.D., Ma L., Chen D.Y. In vitro and in vivo studies evaluating recombinant plasmid pCXN2-mIzumo as a potential immunocontraceptive antigen. Am. J. Reprod. Immunol. 2009, 61:227-235.
5. Angulo E., Cooke B. First synthesize new viruses then regulate their release? The case of the wild rabbit. Mol. Ecol. 2002, 11:2703-2709.
6. Avenarius M.R., Hildebrand M.S., Zhang Y., Meyer N.C., Smith L.L., Kahrizi K., Najmabadi H., Smith R.J. Human male infertility caused by mutations in the CATSPER1 channel protein. Am. J. Hum. Genet. 2009, 84:505-510.
7. Bagavant H., Thillai-Koothan P., Sharma M.G., Talwar G.P., Gupta S.K. Antifertility effects of porcine zona pellucida-3 immunization using permissible adjuvants in female bonnet monkeys (Macaca radiata): reversibility, effect on follicular development and hormonal profiles. J. Reprod. Fertil. 1994, 102:17-25.
8. Baskin M.J. Temporary sterilization by injection of human spermatozoa: a preliminary report. Am. J. Obstet. Gynecol. 1932, 24:892-897.
9. Bermudez-Humaran L.G., Cortes-Perez N.G., Lefevre F., Guimaraes V., Rabot S., Alcocer-Gonzalez J.M., Gratadoux J.J., Rodriguez-Padilla C., Tamez-Guerra R.S., Corthier G., et al. A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors. J. Immunol. 2005, 175:7297-7302.
10. Bhatnagar P., Gupta S.K., Sehgal S. Immunogenicity of deglycosylated zona pellucida antigens and their inhibitory effects on fertility in rabbits. Int. J. Fertil. 1992, 37:53-63.
11. Blackmore D.G., Baillie L.R., Holt J.E., Dierkx L., Aitken R.J., McLaughlin E.A. Biosynthesis of the canine zona pellucida requires the integrated participation of both oocytes and granulosa cells. Biol. Reprod. 2004, 71:661-668.
12. Bleil J.D., Wassarman P.M. Identification of a ZP3-binding protein on acrosome-intact mouse sperm by photoaffinity crosslinking. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:5563-5567.
13. Bowen R.A. Male contraceptive technology for nonhuman male mammals. Anim. Reprod. Sci. 2008, 105:139-143.
14. Brandtzaeg P., Valnes K., Scott H., Rognum T.O., Bjerke K., Baklien K. The human gastrointestinal secretory immune system in health and disease. Scand. J. Gastroenterol. Suppl. 1985, 114:17-38.
15. Busso D., Cohen D.J., Da Ros V., Fissore R., Cuasnicu P.S. Studies on the participation of epididymal sperm protein DE/CRISP-1 in egg activation. Cell. Mol. Biol. (Noisy-le-grand) 2003, 49:407-412.
16. Carlson A.E., Quill T.A., Westenbroek R.E., Schuh S.M., Hille B., Babcock D.F. Identical phenotypes of CatSper1 and CatSper2 null sperm. J. Biol. Chem. 2005, 280:32238-32244.
17. Chen Y., Zhang D., Xin N., Xiong Y., Chen P., Li B., Tu X., Lan F. Construction of sperm-specific lactate dehydrogenase DNA vaccine and experimental study of its immunocontraceptive effect on mice. Sci. China C: Life Sci. 2008, 51:308-316.
18. Chen Z., He W., Liang Z., Yan P., He H., Tang Y., Zhang J., Shen Z., Ni B., Wu Y., et al. Protein prime-peptide boost as a new strategy induced an Eppin dominant B-cell epitope specific immune response and suppressed fertility. Vaccine 2009, 27:733-740.
19. Chua B.Y., Eriksson E.M., Brown L.E., Zeng W., Gowans E.J., Torresi J., Jackson D.C. A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection. Vaccine 2008, 26:4866-4875.
20. Chua B.Y., Zeng W., Lau Y.F., Jackson D.C. Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups. Vaccine 2007, 25:92-101.
21. Claus R., Rottner S., Rueckert C. Individual return to Leydig cell function after GnRH-immunization of boars. Vaccine 2008, 26:4571-4578.
22. Cohen D.J., Ellerman D.A., Busso D., Morgenfeld M.M., Piazza A.D., Hayashi M., Young E.T., Kasahara M., Cuasnicu P.S. Evidence that human epididymal protein ARP plays a role in gamete fusion through complementary sites on the surface of the human egg. Biol. Reprod. 2001, 65:1000-1005.
23. Conforti V.A., de Avila D.M., Cummings N.S., Wells K.J., Ulker H., Reeves J.J. The effectiveness of a CpG motif-based adjuvant (CpG ODN 2006) for LHRH immunization. Vaccine 2007, 25:6537-6543.
24. Conforti V.A., de Avila D.M., Cummings N.S., Zanella R., Wells K.J., Ulker H., Reeves J.J. CpG motif-based adjuvant as a replacement for Freund's complete adjuvant in a recombinant LHRH vaccine. Vaccine 2008, 26:907-913.
25. Conley M.E., Brown P., Bartelt M.S. IgG subclass potential of surface IgM-negative and surface IgM-positive human peripheral blood B cells. Clin. Immunol. Immunopathol. 1987, 43:211-222.
26. Cortes-Perez N.G., Lefevre F., Corthier G., Adel-Patient K., Langella P., Bermudez-Humaran L.G. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine 2007, 25:6581-6588.
27. Cui C., Stevens V.C., Schwendeman S.P. Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccine. Vaccine 2007, 25:500-509.
28. Cunningham K.A., Carey A.J., Lycke N., Timms P., Beagley K.W. CTA1-DD is an effective adjuvant for targeting anti-chlamydial immunity to the murine genital mucosa. J. Reprod. Immunol. 2009, 81:34-38.
29. Darhower S.E., Maher C.R. Effects of immunocontraception on behavior in fallow deer (Dama dama). Zoo Biol. 2008, 27:49-61.
30. Delsink A.K., van Altena J.J., Grobler D., Bertschinger H.J., Kirkpatrick J.F., Slotow R. Implementing immunocontraception in free-ranging African elephants at Makalali conservancy. J. S. Afr. Vet. Assoc. 2007, 78:25-30.
31. Delves P.J., Iles R.K., Roitt I.M., Lund T. Designing a new generation of anti-hCG vaccines for cancer therapy. Mol. Cell. Endocrinol. 2007, 260-262:276-281.
32. Deredec A., Berec L., Boukal D.S., Courchamp F. Are non-sexual models appropriate for predicting the impact of virus-vectored immunocontraception?. J. Theor. Biol. 2008, 250:281-290.
33. Diekman A.B., Norton E.J., Klotz K.L., Westbrook V.A., Shibahara H., Naaby-Hansen S., Flickinger C.J., Herr J.C. N-linked glycan of a sperm CD52 glycoform associated with human infertility. FASEB J. 1999, 13:1303-1313.
34. Dietl J., Freye J., Mettler L. Fertility inhibition using low-dose immunization with procine zonae pellucidae. Am. J. Reprod. Immunol. 1982, 2:153-156.
35. Drell D.W., Wood D.M., Bundman D., Dunbar B.S. Immunological comparison of antibodies to porcine zonae pellucidae in rats and rabbits. Biol. Reprod. 1984, 30:435-444.
36. Duckworth J.A., Wilson K., Cui X., Molinia F.C., Cowan P.E. Immunogenicity and contraceptive potential of three infertility-relevant zona pellucida 2 epitopes in the marsupial brushtail possum (Trichosurus vulpecula). Reproduction 2007, 133:177-186.
37. Eade J.A., Roberston I.D., James C.M. Contraceptive potential of porcine and feline zona pellucida A, B and C subunits in domestic cats. Reproduction 2009, 137:913-922.
38. Earl E.R., Waterston M.M., Aughey E., Harvey M.J., Matschke C., Colston A., Ferro V.A. Evaluation of two GnRH-I based vaccine formulations on the testes function of entire Suffolk cross ram lambs. Vaccine 2006, 24:3172-3183.
39. Ellerman D.A., Brantua V.S., Martinez S.P., Cohen D.J., Conesa D., Cuasnicu P.S. Potential contraceptive use of epididymal proteins: immunization of male rats with epididymal protein DE inhibits sperm fusion ability. Biol. Reprod. 1998, 59:1029-1036.
40. Ellerman D.A., Busso D., Maldera J.A., Cuasnicu P.S. Immunocontraceptive properties of recombinant sperm protein DE: implications for the development of novel contraceptives. Fertil. Steril. 2008, 89:199-205.
41. Ellerman D.A., Cohen D.J., Da Ros V.G., Morgenfeld M.M., Busso D., Cuasnicu P.S. Sperm protein " DE" mediates gamete fusion through an evolutionarily conserved site of the CRISP family. Dev. Biol. 2006, 297:228-237.
42. Evans T.G., McElrath M.J., Matthews T., Montefiori D., Weinhold K., Wolff M., Keefer M.C., Kallas E.G., Corey L., Gorse G.J., et al. QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans. Vaccine 2001, 19:2080-2091.
43. Fayrer-Hosken R. Controlling animal populations using anti-fertility vaccines. Reprod. Domest. Anim. 2008, 43(Suppl. 2):179-185.
44. Fuchs T., Thun R., Parvizi N., Nathues H., Koehrmann A., Andrews S., Brock F., Klein G., Sudhaus N., Beilage E.G. Effect of a gonadotropin-releasing factor vaccine on follicle-stimulating hormone and luteinizing hormone concentrations and on the development of testicles and the expression of boar taint in male pigs. Theriogenology 2009, 72:672-680.
45. Fujihashi K., Koga T., van Ginkel F.W., Hagiwara Y., McGhee J.R. A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants. Vaccine 2002, 20:2431-2438.
46. Gallichan W.S., Rosenthal K.L. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization. J. Infect. Dis. 1998, 177:1155-1161.
47. Goldberg E. Developmental expression of lactate dehydrogenase isozymes during spermatogenesis. Prog. Clin. Biol. Res. 1990, 344:49-52.
48. Gorman S., Lloyd M.L., Smith L.M., McWhorter A.R., Lawson M.A., Redwood A.J., Shellam G.R. Prior infection with murine cytomegalovirus (MCMV) limits the immunocontraceptive effects of an MCMV vector expressing the mouse zona-pellucida-3 protein. Vaccine 2008, 26:3860-3869.
49. Gu W., Holland M., Janssens P., Kerr P. Antibody response in the female rabbit reproductive tract to influenza haemagglutinin encoded by a recombinant myxoma virus. Virology 2003, 313:286-295.
50. Haase A.T. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 2010, 464:217-223.
51. Hansen S.G., Vieville C., Whizin N., Coyne-Johnson L., Siess D.C., Drummond D.D., Legasse A.W., Axthelm M.K., Oswald K., Trubey C.M., et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 2009, 15:293-299.
52. Harandi A.M., Holmgren J. CpG DNA as a potent inducer of mucosal immunity: implications for immunoprophylaxis and immunotherapy of mucosal infections. Curr. Opin. Investig. Drugs 2004, 5:141-145.
53. Hardy C.M. Current status of virally vectored immunocontraception for biological control of mice. Soc. Reprod. Fertil. Suppl. 2007, 63:495-506.
54. Hardy C.M., Beaton S., Hinds L.A. Immunocontraception in mice using repeated, multi-antigen peptides: immunization with purified recombinant antigens. Mol. Reprod. Dev. 2008, 75:126-135.
55. Hardy C.M., Braid A.L. Vaccines for immunological control of fertility in animals. Rev. Sci. Tech. 2007, 26:461-470.
56. Hardy C.M., Hinds L.A., Kerr P.J., Lloyd M.L., Redwood A.J., Shellam G.R., Strive T. Biological control of vertebrate pests using virally vectored immunocontraception. J. Reprod. Immunol. 2006, 71:102-111.
57. Herr J.C., Wright R.M., John E., Foster J., Kays T., Flickinger C.J. Identification of human acrosomal antigen SP-10 in primates and pigs. Biol. Reprod. 1990, 42:377-382.
58. Hickey D.K., Jones R.C., Bao S., Blake A.E., Skelding K.A., Berry L.J., Beagley K.W. Intranasal immunization with C. muridarum major outer membrane protein (MOMP) and cholera toxin elicits local production of neutralising IgA in the prostate. Vaccine 2004, 22:4306-4315.
59. Hull M.G., Glazener C.M., Kelly N.J., Conway D.I., Foster P.A., Hinton R.A., Coulson C., Lambert P.A., Watt E.M., Desai K.M. Population study of causes, treatment, and outcome of infertility. Br. Med. J. (Clin. Res. Ed.) 1985, 291:1693-1697.
60. Inoue N., Ikawa M., Okabe M. Putative sperm fusion protein IZUMO and the role of N-glycosylation. Biochem. Biophys. Res. Commun. 2008, 377:910-914.
61. Jackson R.J., Maguire D.J., Hinds L.A., Ramshaw I.A. Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3. Biol. Reprod. 1998, 58:152-159.
62. Jagadish N., Rana R., Mishra D., Garg M., Selvi R., Suri A. Characterization of immune response in mice to plasmid DNA encoding human sperm associated antigen 9 (SPAG9). Vaccine 2006, 24:3695-3703.
63. Janett F., Stump R., Burger D., Thun R. Suppression of testicular function and sexual behavior by vaccination against GnRH (Equity) in the adult stallion. Anim. Reprod. Sci. 2009, 115:88-102.
64. Jin J., Jin N., Zheng H., Ro S., Tafolla D., Sanders K.M., Yan W. Catsper3 and Catsper4 are essential for sperm hyperactivated motility and male fertility in the mouse. Biol. Reprod. 2007, 77:37-44.
65. Jones G.R., Sacco A.G., Subramanian M.G., Kruger M., Zhang S., Yurewicz E.C., Moghissi K.S. Histology of ovaries of female rabbits immunized with deglycosylated zona pellucida macromolecules of pigs. J. Reprod. Fertil. 1992, 95:513-525.
66. Kaul R., Afzalpurkar A., Gupta S.K. Strategies for designing an immunocontraceptive vaccine based on zona pellucida synthetic peptides and recombinant antigen. J. Reprod. Fertil. Suppl. 1996, 50:127-134.
67. Kawana K., Yasugi T., Taketani Y. Human papillomavirus vaccines: current issues & future. Indian J. Med. Res. 2009, 130:341-347.
68. Keenan J.A., Sacco A.G., Subramanian M.G., Kruger M., Yurewicz E.C., Moghissi K.S. Endocrine response in rabbits immunized with native versus deglycosylated porcine zona pellucida antigens. Biol. Reprod. 1991, 44:150-156.
69. Kerr P.J., Jackson R.J. Myxoma virus as a vaccine vector for rabbits: antibody levels to influenza virus haemagglutinin presented by a recombinant myxoma virus. Vaccine 1995, 13:1722-1726.
70. Kerr P.J., Jackson R.J., Robinson A.J., Swan J., Silvers L., French N., Clarke H., Hall D.F., Holland M.K. Infertility in female rabbits (Oryctolagus cuniculus) alloimmunized with the rabbit zona pellucida protein ZPB either as a purified recombinant protein or expressed by recombinant myxoma virus. Biol. Reprod. 1999, 61:606-613.
71. Kerr P.J., Perkins H.D., Inglis B., Stagg R., McLaughlin E., Collins S.V., Van Leeuwen B.H. Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis. Virology 2004, 324(1):117-128.
72. Khan M.A., Ferro V.A., Koyama S., Kinugasa Y., Song M., Ogita K., Tsutsui T., Murata Y., Kimura T. Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppresses fertility in vivo. Vaccine 2007, 25:3544-3553.
73. Kharat I., Nair N.S., Dhall K., Sawhney H., Krishna U., Shahani S.M., Banerjee A., Roy S., Kumar S., Hingorani V., et al. Analysis of menstrual records of women immunized with anti-hCG vaccines inducing antibodies partially cross-reactive with hLH. Contraception 1990, 41:293-299.
74. Killian G., Kreeger T.J., Rhyan J., Fagerstone K., Miller L. Observations on the use of GonaCon in captive female elk (Cervus elaphus). J. Wildl. Dis. 2009, 45:184-188.
75. Killian G., Miller L., Rhyan J., Doten H. Immunocontraception of Florida feral swine with a single-dose GnRH vaccine. Am. J. Reprod. Immunol. 2006, 55:378-384.
76. Kirkpatrick J.F., Rowan A., Lamberski N., Wallace R., Frank K., Lyda R. The practical side of immunocontraception: zona proteins and wildlife. J. Reprod. Immunol. 2009, 83:151-157.
77. Kitchener A.L., Edds L.M., Molinia F.C., Kay D.J. Porcine zonae pellucidae immunization of tammar wallabies (Macropus eugenii): fertility and immune responses. Reprod. Fertil. Dev. 2002, 14:215-223.
78. Kitchener A.L., Harman A., Kay D.J., McCartney C.A., Mate K.E., Rodger J.C. Immunocontraception of Eastern Grey kangaroos (Macropus giganteus) with recombinant brushtail possum (Trichosurus vulpecula) ZP3 protein. J. Reprod. Immunol. 2009, 79:156-162.
79. Klinman D.M., Klaschik S., Sato T., Tross D. CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases. Adv. Drug Deliv. Rev. 2009, 61:248-255.
80. Kurth B.E., Digilio L., Snow P., Bush L.A., Wolkowicz M., Shetty J., Mandal A., Hao Z., Reddi P.P., Flickinger C.J., et al. Immunogenicity of a multi-component recombinant human acrosomal protein vaccine in female Macaca fascicularis. J. Reprod. Immunol. 2008, 77:126-141.
81. Kutteh W.H., Prince S.J., Hammond K.R., Kutteh C.C., Mestecky J. Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation. Clin. Exp. Immunol. 1996, 104:538-542.
82. Lane V.M., Liu I.K., Casey K., vanLeeuwen E.M., Flanagan D.R., Murata K., Munro C. Inoculation of female American black bears (Ursus americanus) with partially purified porcine zona pellucidae limits cub production. Reprod. Fertil. Dev. 2007, 19:617-625.
83. Lea I.A., Adoyo P., O'Rand M.G. Autoimmunogenicity of the human sperm protein Sp17 in vasectomized men and identification of linear B cell epitopes. Fertil. Steril. 1997, 67:355-361.
84. Lefevre A., Martin Ruiz C., Chokomian S., Duquenne C., Finaz C. Characterization and isolation of SOB2, a human sperm protein with a potential role in oocyte membrane binding. Mol. Hum. Reprod. 1997, 3:507-516.
85. Li H., Ding X., Guan H., Xiong C. Inhibition of human sperm function and mouse fertilization in vitro by an antibody against cation channel of sperm. 1. The contraceptive potential of its transmembrane domains and pore region. Fertil. Steril. 2009, 92:1141-1146.
86. Li H.G., Liao A.H., Ding X.F., Zhou H., Xiong C.L. The expression and significance of CATSPER1 in human testis and ejaculated spermatozoa. Asian J. Androl. 2006, 8:301-306.
87. Li H.P., He X.J., Tang C.L., Yao X.Y., Li D.J. Fusion of hC3d3 to hCGbeta enhances responsiveness in vitro of human peripheral immunocompetent cells upon the antigen primary challenge. J. Reprod. Immunol. 2008, 78:115-124.
88. Lindqvist M., Persson J., Thorn K., Harandi A.M. The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection. J. Immunol. 2009, 182:6435-6443.
89. Lloyd M.L., Nikolovski S., Lawson M.A., Shellam G.R. Innate antiviral resistance influences the efficacy of a recombinant murine cytomegalovirus immunocontraceptive vaccine. Vaccine 2007, 25:679-690.
90. Locke S.L., Cook M.W., Harveson L.A., Davis D.S., Lopez R.R., Silvy N.J., Fraker M.A. Effectiveness of Spayvac for reducing white-tailed deer fertility. J. Wildl. Dis. 2007, 43:726-730.
91. Lycke N. From toxin to adjuvant: the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM. Cell. Microbiol. 2004, 6:23-32.
92. Mackenzie S.M., McLaughlin E.A., Perkins H.D., French N., Sutherland T., Jackson R.J., Inglis B., Muller W.J., van Leeuwen B.H., Robinson A.J., et al. Immunocontraceptive effects on female rabbits infected with recombinant myxoma virus expressing rabbit ZP2 or ZP3. Biol. Reprod. 2006, 74:511-521.
93. Mancini R.E., Andrada J.A., Saraceni D., Bachmann A.E., Lavieri J.C., Nemirovsky M. Immunological and testicular response in man sensitized with human testicular homogenate. J. Clin. Endocrinol. Metab. 1965, 25:859-875.
94. McLaughlin E.A., Frayne J., Barker H.L., Jury J.A., Jones R., Ford W.C., Hall L. Cloning and sequence analysis of rat fertilin alpha and beta-developmental expression, processing and immunolocalization. Mol. Hum. Reprod. 1997, 3:801-809.
95. McLaughlin E.A., Frayne J., Bloomerg G., Hall L. Do fertilin beta and cyritestin play a major role in mammalian sperm-oolemma interactions? A critical re-evaluation of the use of peptide mimics in identifying specific oocyte recognition protiens. Mol. Hum. Reprod. 2001, 7:313-317.
96. McLaughlin E.A., Holland M.K., Aitken R.J. Contraceptive vaccines. Expert. Opin. Biol. Ther. 2003, 3:829-841.
97. McLaughlin E.A., McIver S.C. Awakening the oocyte: controlling primordial follicle development. Reproduction 2009, 137:1-11.
98. McNatty K.P., Hudson N.L., Whiting L., Reader K.L., Lun S., Western A., Heath D.A., Smith P., Moore L.G., Juengel J.L. The effects of immunizing sheep with different BMP15 or GDF9 peptide sequences on ovarian follicular activity and ovulation rate. Biol. Reprod. 2007, 76:552-560.
99. McNatty K.P., Lawrence S., Groome N.P., Meerasahib M.F., Hudson N.L., Whiting L., Heath D.A., Juengel J.L. Meat and Livestock Association Plenary Lecture 2005. Oocyte signalling molecules and their effects on reproduction in ruminants. Reprod. Fertil. Dev. 2006, 18:403-412.
100. Menkhorst E., Salamonsen L., Robb L., Dimitriadis E. IL11 antagonist inhibits uterine stromal differentiation, causing pregnancy failure in mice. Biol. Reprod. 2009, 80:920-927.
101. Menkhorst E.M., Cui S., Selwood L. Novel immunocontraceptive targets in mammals: uterine secretions and the conceptus; a marsupial approach. Reproduction 2008, 136:471-480.
102. Mestecky J., Eldridge J.H. Targeting and controlled release of antigens for the effective induction of secretory antibody responses. Curr. Opin. Immunol. 1991, 3:492-495.
103. Miller L.A., Gionfriddo J.P., Fagerstone K.A., Rhyan J.C., Killian G.J. The single-shot GnRH immunocontraceptive vaccine (GonaCon) in white-tailed deer: comparison of several GnRH preparations. Am. J. Reprod. Immunol. 2008, 60:214-223.
104. Miller L.A., Johns B.E., Killian G.J. Immunocontraception of white-tailed deer using native and recombinant zona pellucida vaccines. Anim. Reprod. Sci. 2000, 63:187-195.
105. Mruk D.D. New perspectives in non-hormonal male contraception. Trends Endocrinol. Metab. 2008, 19:57-64.
106. Mutsch M., Zhou W., Rhodes P., Bopp M., Chen R.T., Linder T., Spyr C., Steffen R. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N. Engl. J. Med. 2004, 350:896-903.
107. Nakano M., Yonezawa N. Localization of sperm ligand carbohydrate chains in pig zona pellucida glycoproteins. Cells Tissues Organs 2001, 168:65-75.
108. Nash H., Johansson E.D., Talwar G.P., Vasquez J., Segal S., Coutinho E., Luukkainen T., Sundaram K. Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: beta-subunit of human chorionic gonadotropin linked to tetanus toxoid. Fertil. Steril. 1980, 34:328-335.
109. Nation A., Cui S., Selwood L. Vesicle-associated protein 1: a novel ovarian immunocontraceptive target in the common brushtail possum, Trichosurus vulpecula. Reproduction 2008, 136:657-665.
110. Naz R., Aleem A. Effect of immunization with six sperm peptide vaccines on fertility of female mice. Soc. Reprod. Fertil. Suppl. 2007, 63:455-464.
111. Naz R.K., Rowan S. Update on male contraception. Curr. Opin. Obstet. Gynecol. 2009, 21:265-269.
112. Naz R.K., Wolf D.P. Antibodies to sperm-specific human FA-1 inhibit in vitro fertilization in rhesus monkeys: development of a simian model for testing of anti-FA-1 contraceptive vaccine. J. Reprod. Immunol. 1994, 27:111-121.
113. Nie G., Findlay J.K., Salamonsen L.A. Identification of novel endometrial targets for contraception. Contraception 2005, 71:272-281.
114. Nikolovski S., Lloyd M.L., Harvey N., Hardy C.M., Shellam G.R., Redwood A.J. Overcoming innate host resistance to vaccination: employing a genetically distinct strain of murine cytomegalovirus avoids vector-mediated resistance to virally vectored immunocontraception. Vaccine 2009, 27:5226-5232.
115. Nixon B., Aitken R.J., McLaughlin E.A. New insights into the molecular mechanisms of sperm-egg interaction. Cell. Mol. Life Sci. 2007, 64:1805-1823.
116. O'Leary S., Lloyd M.L., Shellam G.R., Robertson S.A. Immunization with recombinant murine cytomegalovirus expressing murine zona pellucida 3 causes permanent infertility in BALB/c mice due to follicle depletion and ovulation failure. Biol. Reprod. 2008, 79:849-860.
117. O'Rand M.G., Widgren E.E., Beyler S., Richardson R.T. Inhibition of human sperm motility by contraceptive anti-eppin antibodies from infertile male monkeys: effect on cyclic adenosine monophosphate. Biol. Reprod. 2009, 80:279-285.
118. O'Rand M.G., Widgren E.E., Wang Z., Richardson R.T. Eppin: an epididymal protease inhibitor and a target for male contraception. Soc. Reprod. Fertil. Suppl. 2007, 63:445-453.
119. Parlane N.A., Denis M., Severn W.B., Skinner M.A., Painter G.F., La Flamme A.C., Ainge G.D., Larsen D.S., Buddle B.M. Phosphatidylinositol mannosides are efficient mucosal adjuvants. Immunol. Invest. 2008, 37:129-142.
120. Parry S., Wong N.K., Easton R.L., Panico M., Haslam S.M., Morris H.R., Anderson P., Klotz K.L., Herr J.C., Diekman A.B., et al. The sperm agglutination antigen-1 (SAGA-1) glycoforms of CD52 are O-glycosylated. Glycobiology 2007, 17:1120-1126.
121. Paterson M., Wilson M.R., Jennings Z.A., van Duin M., Aitken R.J. Design and evaluation of a ZP3 peptide vaccine in a homologous primate model. Mol. Hum. Reprod. 1999, 5:342-352.
122. Prasad S.V., Mujtaba S., Lee V.H., Dunbar B.S. Immunogenicity enhancement of recombinant rabbit 55-kilodalton zona pellucida protein expressed using the baculovirus expression system. Biol. Reprod. 1995, 52:1167-1178.
123. Primakoff P., Hyatt H., Tredick-Kline J. Identification and purification of a sperm surface protein with a potential role in sperm-egg membrane fusion. J. Cell Biol. 1987, 104:141-149.
124. Primakoff P., Lathrop W., Woolman L., Cowan A., Myles D. Fully effective contraception in male and female guinea pigs immunized with the sperm protein PH-20. Nature 1988, 335:543-546.
125. Redwood A.J., Harvey N.L., Lloyd M., Lawson M.A., Hardy C.M., Shellam G.R. Viral vectored immunocontraception: screening of multiple fertility antigens using murine cytomegalovirus as a vaccine vector. Vaccine 2007, 25:698-708.
126. Redwood A.J., Messerle M., Harvey N.L., Hardy C.M., Koszinowski U.H., Lawson M.A., Shellam G.R. Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception. J. Virol. 2005, 79:2998-3008.
127. Rerks-Ngarm S., Pitisuttithum P., Nitayaphan S., Kaewkungwal J., Chiu J., Paris R., Premsri N., Namwat C., de Souza M., Adams E., et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 2009, 361:2209-2220.
128. Riedmann E.M., Kyd J.M., Cripps A.W., Lubitz W. Bacterial ghosts as adjuvant particles. Expert. Rev. Vaccines 2007, 6:241-253.
129. Robinson A.J., Jackson R., Kerr P., Merchant J., Parer I., Pech R. Progress towards using recombinant myxoma virus as a vector for fertility control in rabbits. Reprod. Fertil. Dev. 1997, 9:77-83.
130. Rose N.R., Burek C.L., Smith J.P. Safety evaluation of hCG vaccine in primates: auto-antibodies production. Contraception Research for Today and Nineties 1988, 231-239. Springer-Verlag, New York. G.P. Talwar (Ed.).
131. Rosenthal K.L., Gallichan W.S. Challenges for vaccination against sexually-transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract. Semin. Immunol. 1997, 9:303-314.
132. Russell M.W., Moldoveanu Z., White P.L., Sibert G.J., Mestecky J., Michalek S.M. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit. Infect. Immun. 1996, 64:1272-1283.
133. Sacco A.G. Immunocontraception: consideration of the zona pellucida as a target antigen. Obstet. Gynecol. Annu. 1981, 10:1-26.
134. Sacco A.G., Yurewicz E.C., Subramanian M.G., Matzat P.D. Porcine zona pellucida: association of sperm receptor activity with the alpha-glycoprotein component of the Mr=55,000 family. Biol. Reprod. 1989, 41:523-532.
135. Salamonsen L.A., Nie G., Findlay J.K. Newly identified endometrial genes of importance for implantation. J. Reprod. Immunol. 2002, 53:215-225.
136. Samuel A.S., Naz R.K. Isolation of human single chain variable fragment antibodies against specific sperm antigens for immunocontraceptive development. Hum. Reprod. 2008, 23:1324-1337.
137. Seamark R.F. Biotech prospects for the control of introduced mammals in Australia. Reprod. Fertil. Dev. 2001, 13:705-711.
138. Sehgal S., Gupta S.K., Bhatnagar P. Long-term effects of immunization with porcine zona pellucida on rabbit ovaries. Pathology 1989, 21:105-110.
139. Shi J., Yang Z., Wang M., Cheng G., Li D., Wang Y., Zhou Y., Liu X., Xu C. Screening of an antigen target for immunocontraceptives from cross-reactive antigens between human sperm and Ureaplasma urealyticum. Infect. Immun. 2007, 75:2004-2011.
140. Skinner S.M., Mills T., Kirchick H.J., Dunbar B.S. Immunization with zona pellucida proteins results in abnormal ovarian follicular differentiation and inhibition of gonadotropin-induced steroid secretion. Endocrinology 1984, 115:2418-2432.
141. Spargo S.C., Hope R.M. Evolution and nomenclature of the zona pellucida gene family. Biol. Reprod. 2003, 68:358-362.
142. Sun J., Xia H.F., Yang Y., Peng J.P. The antifertility effects of DNA vaccine-induced immune responses against uroguanylin. Vaccine 2008, 26:3696-3704.
143. Talbot P., Shur B.D., Myles D.G. Cell adhesion and fertilization: steps in oocyte transport, sperm-zona pellucida interactions, and sperm-egg fusion. Biol. Reprod. 2003, 68:1-9.
144. Talwar G.P. Fertility regulating and immunotherapeutic vaccines reaching human trials stage. Hum. Reprod. Update 1997, 3:301-310.
145. Talwar G.P. Vaccines and passive immunological approaches for the control of fertility and hormone-dependent cancers. Immunol. Rev. 1999, 171:173-192.
146. Talwar G.P., Hingorani V., Kumar S., Roy S., Banerjee A., Shahani S.M., Krishna U., Dhall K., Sawhney H., Sharma N.C., et al. Phase I clinical trials with three formulations of anti-human chorionic gonadotropin vaccine. Contraception 1990, 41:301-316.
147. Talwar G.P., Sharma N.C., Dubey S.K., Salahuddin M., Das C., Ramakrishnan S., Kumar S., Hingorani V. Isoimmunization against human chorionic gonadotropin with conjugates of processed beta-subunit of the hormone and tetanus toxoid. Proc. Natl. Acad. Sci. U.S.A. 1976, 73:218-222.
148. Talwar G.P., Singh O., Pal R., Chatterjee N., Sahai P., Dhall K., Kaur J., Das S.K., Suri S., Buckshee K., et al. A vaccine that prevents pregnancy in women. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:8532-8536.
149. Talwar G.P., Singh O.M., Gupta S.K., Hasnain S.E., Pal R., Majumbar S.S., Vrati S., Mukhopadhay A., Srinivasan J., Deshmukh U., et al. The HSD-hCG vaccine prevents pregnancy in women: feasibility study of a reversible safe contraceptive vaccine. Am. J. Reprod. Immunol. 1997, 37:153-160.
150. Talwar G.P., Vyas H.K., Purswani S., Gupta J.C. Gonadotropin-releasing hormone/human chorionic gonadotropin beta based recombinant antibodies and vaccines. J. Reprod. Immunol. 2009, 83:158-163.
151. Tovey M.G., Lallemand C., Thyphronitis G. Adjuvant activity of type I interferons. Biol. Chem. 2008, 389(5):541-545.
152. Turner J.W., Liu I.K., Kirkpatrick J.F. Remotely delivered immunocontraception in free-roaming feral burros (Equus asinus). J. Reprod. Fertil. 1996, 107:31-35.
153. Tyndale-Biscoe C.H. Virus-vectored immunocontraception of feral mammals. Reprod. Fertil. Dev. 1994, 6:281-287.
154. Virgin H.W., Walker B.D. Immunology and the elusive AIDS vaccine. Nature 2010, 464:224-231.
155. Walker J., Ghosh S., Pagnon J., Colantoni C., Newbold A., Zeng W., Jackson D.C. Totally synthetic peptide-based immunocontraceptive vaccines show activity in dogs of different breeds. Vaccine 2007, 25:7111-7119.
156. Wang D.G., Huang T.H., Xie Q.D., An G. Investigation of recombinant mouse sperm protein izumo as a potential immunocontraceptive antigen. Am. J. Reprod. Immunol. 2008, 59:225-234.
157. Wang M., Lv Z., Shi J., Hu Y., Xu C. Immunocontraceptive potential of the Ig-like domain of Izumo. Mol. Reprod. Dev. 2009, 76:794-801.
158. Wang M., Shi J.L., Cheng G.Y., Hu Y.Q., Xu C. The antibody against a nuclear autoantigenic sperm protein can result in reproductive failure. Asian J. Androl. 2009, 11:183-192.
159. Wang Z., Widgren E.E., Richardson R.T., O'Rand M.G. Characterization of an eppin protein complex from human semen and spermatozoa. Biol. Reprod. 2007, 77:476-484.
160. White C.A., Zhang J.G., Salamonsen L.A., Baca M., Fairlie W.D., Metcalf D., Nicola N.A., Robb L., Dimitriadis E. Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: a nonhormonal contraceptive strategy. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:19357-19362.
161. Wright A.K., Briles D.E., Metzger D.W., Gordon S.B. Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection. Vaccine 2008, 26:4893-4903.
162. Xu B., Copolla M., Herr J.C., Timko M.P. Expression of a recombinant human sperm-agglutinating mini-antibody in tobacco (Nicotiana tabacum L.). Soc. Reprod. Fertil. Suppl. 2007, 63:465-477.
163. Yao X.Y., Yuan M.M., Li D.J. Mucosal inoculation of Lactobacillus expressing hCGbeta induces an anti-hCGbeta antibody response in mice of different strains. Methods 2006, 38:124-132.
164. Yurewicz E.C., Sacco A.G., Gupta S.K., Xu N., Gage D.A. Hetero-oligomerization-dependent binding of pig oocyte zona pellucida glycoproteins ZPB and ZPC to boar sperm membrane vesicles. J. Biol. Chem. 1998, 273:7488-7494.
165. Zhao M., Dean J. The zona pellucida in folliculogenesis, fertilization and early development. Rev. Endocr. Metab. Disord. 2002, 3:19-26.